Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2017-07-01
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Detection of Glycocalyx Damage in Emergency Room Patients
NCT03126032
Evaluation of Impaired Microcirculation During Septic Shock With Contrast Enhanced Ultrasound
NCT02277977
Proadrenomedullin and Microcirculation in Monitoring Organ Dysfunction in Patient With Infection
NCT03931967
Analysis of Sublingual Glycocalyx Damage at ICU Admission to Predict Risk of Death
NCT03847493
Mitochondrial Function in Septic Patients
NCT03748537
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Septic patients
ICU patients with resuscitated sepsis, based on the sepsis-3 criteria. (n=30)
Microcirculation and Glycocalyx assessment
Non-invasive assessment of endothelial glycocalyx dimensions (PBR) and microcirculatory parameters (e.g. PPV, PVD, TVD, MFI)
Healthy controls
Apparently healthy controls (n=10)
Microcirculation and Glycocalyx assessment
Non-invasive assessment of endothelial glycocalyx dimensions (PBR) and microcirculatory parameters (e.g. PPV, PVD, TVD, MFI)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microcirculation and Glycocalyx assessment
Non-invasive assessment of endothelial glycocalyx dimensions (PBR) and microcirculatory parameters (e.g. PPV, PVD, TVD, MFI)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ICU stay
\- Adult healthy individuals
Exclusion Criteria
* pregnancy
* oral mucosal inflammation or injury
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Muenster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philipp Kümpers, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Muenster
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitiy Hospital Muenster
Münster, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rovas A, Seidel LM, Vink H, Pohlkotter T, Pavenstadt H, Ertmer C, Hessler M, Kumpers P. Association of sublingual microcirculation parameters and endothelial glycocalyx dimensions in resuscitated sepsis. Crit Care. 2019 Jul 24;23(1):260. doi: 10.1186/s13054-019-2542-2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IDF_SDF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.